eficur 50 mg/ml injekčná suspenzia pre ošípané a hovädzí dobytok
laboratorios hipra s.a, Španielsko - inj.
eradia 125 mg/ml perorálna suspenzia pre psy
virbac, francúzsko - susp.
excenel fluid 50 mg/ml injekčná suspenzia
zoetis Česká republika, Česká republika - inj.
marbodex ušné kvapky, suspenzia pre psy
norbrook laboratories, severné Írsko - gtt.oto.
masti veyxym
veyx-pharma, srn - ung.
adatam 0,5 mg/0,4 mg
adamed pharma s.a., poľsko - tamsulozín a dutasterid - 77 - sympatholytica
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidémia - Činidlá modifikujúce lipidy - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
prosaro 250 ec
bayer ag - emulgovateľný koncentrát - prothioconazole 125 g/l; prothioconazole 125 g/l
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastické činidlá - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
slape trio
adama - ec - prothioconazole 53 g/l + spiroxamine 224 g/l + tebuconazole 148 g/l - fungicíd